Genomics Medicine Ireland Opens Dublin Clinic for Precision Medicine Research

Genomics Medicine Ireland (GMI), the recently-acquired Irish subsidiary of WuXi NextCode, said today it has opened a research clinic in Dublin’s City Centre hub,...

Thermo Fisher, NX Prenatal to Develop NIPT Proteomics Assays

Thermo Fisher Scientific will combine its liquid chromatography-mass spectrometry (LC-MS) instrumentation with NX Prenatal’s NeXosome platform to develop proteomics assays designed to offer noninvasive...

DNAnexus, UPMC, Sutter Health Launch Clinico-Genomic MS Precision Medicine Study

Clinico-genomic research study aims to improve personalized treatments for people with multiple sclerosis

Sophia Genetics Gains CE-IVD Marking for Solid Tumor Solution

Sophia Genetics has obtained the CE-IVD marking for its Solid Tumor Solution (STS), a molecular diagnostic application designed to precisely detect and characterize all...

Myriad Genetics Expands CDx Collaboration with AstraZeneca, Merck & Co.

Myriad Genetics said today it has expanded its companion diagnostic collaboration with AstraZeneca and Merck & Co., which have agreed to use Myriad’s BRACAnalysis...

BGI Americas, AiLife Partner on Clinical WGS Diagnostics for Genetic Disorders

BGI Americas, the U.S. subsidiary of BGI Genomics, will partner with AiLife Diagnostics to jointly develop and market a clinical whole genome sequencing (WGS)...

PerkinElmer, Helix Partner to Launch Genetic Screening Test

The DNA test available to healthy individuals analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics.

LabCorp’s Covance to Offer Services via Mission Bio’s Tapestri Platform

LabCorp’s Covance Drug Development business will be the first global contract research organization to offer services on Mission Bio’s Tapestri Platform for single-cell DNA genomics.

Guardant to Acquire Bellwether Bio, Adding to Early-Stage Cancer Dx Pipeline

Guardant Health will acquire Bellwether Bio, in a deal designed to advance the buyer’s pipeline of early-detection cancer diagnostics.
Array of blood samples for microscopy

Consortium’s New Liquid Biopsy Method Shows Promising Results in NSCLC

The researchers used Illumina’s “ultra-deep” next-generation sequencing of cell-free DNA (cfDNA) to accurately detect variants from any of 37 genes commonly associated with lung cancer.
Scroll Up